“The idea of a shame-based economy isn’t too far off,” said Andrew Friedson, Assistant Professor of Economics. “Consumers have little power to engage in direct bargaining to get a better deal.”

With insulin price cap, drug industry is once again shamed into doing the right thing
Los Angeles Times, April 4